These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 19383787)

  • 1. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity.
    Zhang YJ; Xu YF; Cook C; Gendron TF; Roettges P; Link CD; Lin WL; Tong J; Castanedes-Casey M; Ash P; Gass J; Rangachari V; Buratti E; Baralle F; Golde TE; Dickson DW; Petrucelli L
    Proc Natl Acad Sci U S A; 2009 May; 106(18):7607-12. PubMed ID: 19383787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Igaz LM; Kwong LK; Xu Y; Truax AC; Uryu K; Neumann M; Clark CM; Elman LB; Miller BL; Grossman M; McCluskey LF; Trojanowski JQ; Lee VM
    Am J Pathol; 2008 Jul; 173(1):182-94. PubMed ID: 18535185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [TDP-43 proteinopathies: ALS and frontotemporal dementias].
    Prudlo J
    Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S25-7. PubMed ID: 19685386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43.
    Zhang YJ; Xu YF; Dickey CA; Buratti E; Baralle F; Bailey R; Pickering-Brown S; Dickson D; Petrucelli L
    J Neurosci; 2007 Sep; 27(39):10530-4. PubMed ID: 17898224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Hasegawa M; Arai T; Nonaka T; Kametani F; Yoshida M; Hashizume Y; Beach TG; Buratti E; Baralle F; Morita M; Nakano I; Oda T; Tsuchiya K; Akiyama H
    Ann Neurol; 2008 Jul; 64(1):60-70. PubMed ID: 18546284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Arai T; Hasegawa M; Akiyama H; Ikeda K; Nonaka T; Mori H; Mann D; Tsuchiya K; Yoshida M; Hashizume Y; Oda T
    Biochem Biophys Res Commun; 2006 Dec; 351(3):602-11. PubMed ID: 17084815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies.
    Neumann M; Kwong LK; Lee EB; Kremmer E; Flatley A; Xu Y; Forman MS; Troost D; Kretzschmar HA; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2009 Feb; 117(2):137-49. PubMed ID: 19125255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological Features of TDP-43 Proteinopathies.
    Igaz LM; Kwong LK; Chen-Plotkin A; Winton MJ; Unger TL; Xu Y; Neumann M; Trojanowski JQ; Lee VM
    J Biol Chem; 2009 Mar; 284(13):8516-24. PubMed ID: 19164285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylated and ubiquitinated TDP-43 pathological inclusions in ALS and FTLD-U are recapitulated in SH-SY5Y cells.
    Nonaka T; Arai T; Buratti E; Baralle FE; Akiyama H; Hasegawa M
    FEBS Lett; 2009 Jan; 583(2):394-400. PubMed ID: 19111550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of heterogeneous nuclear ribonucleoproteins and survival motor neuron protein in TDP-43 positive inclusions in frontotemporal lobar degeneration.
    Neumann M; Igaz LM; Kwong LK; Nakashima-Yasuda H; Kolb SJ; Dreyfuss G; Kretzschmar HA; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2007 May; 113(5):543-8. PubMed ID: 17415574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TDP-43: the relationship between protein aggregation and neurodegeneration in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
    Baloh RH
    FEBS J; 2011 Oct; 278(19):3539-49. PubMed ID: 21777387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TDP-43-induced death is associated with altered regulation of BIM and Bcl-xL and attenuated by caspase-mediated TDP-43 cleavage.
    Suzuki H; Lee K; Matsuoka M
    J Biol Chem; 2011 Apr; 286(15):13171-83. PubMed ID: 21339291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitinated, p62 immunopositive cerebellar cortical neuronal inclusions are evident across the spectrum of TDP-43 proteinopathies but are only rarely additionally immunopositive for phosphorylation-dependent TDP-43.
    King A; Maekawa S; Bodi I; Troakes C; Al-Sarraj S
    Neuropathology; 2011 Jun; 31(3):239-49. PubMed ID: 21118398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy.
    Arai T; Hasegawa M; Nonoka T; Kametani F; Yamashita M; Hosokawa M; Niizato K; Tsuchiya K; Kobayashi Z; Ikeda K; Yoshida M; Onaya M; Fujishiro H; Akiyama H
    Neuropathology; 2010 Apr; 30(2):170-81. PubMed ID: 20102522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggregation of the 35-kDa fragment of TDP-43 causes formation of cytoplasmic inclusions and alteration of RNA processing.
    Che MX; Jiang YJ; Xie YY; Jiang LL; Hu HY
    FASEB J; 2011 Jul; 25(7):2344-53. PubMed ID: 21450909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration.
    Wils H; Kleinberger G; Janssens J; Pereson S; Joris G; Cuijt I; Smits V; Ceuterick-de Groote C; Van Broeckhoven C; Kumar-Singh S
    Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3858-63. PubMed ID: 20133711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caspase-cleaved TAR DNA-binding protein-43 is a major pathological finding in Alzheimer's disease.
    Rohn TT
    Brain Res; 2008 Sep; 1228():189-98. PubMed ID: 18634762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine structural analysis of the neuronal inclusions of frontotemporal lobar degeneration with TDP-43 proteinopathy.
    Thorpe JR; Tang H; Atherton J; Cairns NJ
    J Neural Transm (Vienna); 2008 Dec; 115(12):1661-71. PubMed ID: 18974920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody against TDP-43 phosphorylated at serine 375 suggests conformational differences of TDP-43 aggregates among FTLD-TDP subtypes.
    Neumann M; Frick P; Paron F; Kosten J; Buratti E; Mackenzie IR
    Acta Neuropathol; 2020 Nov; 140(5):645-658. PubMed ID: 32778941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoplasmic inclusions of TDP-43 in neurodegenerative diseases: a potential role for caspases.
    Rohn TT
    Histol Histopathol; 2009 Aug; 24(8):1081-6. PubMed ID: 19554515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.